Clinical Trials Sponsored by National Alliance for Research in Schizophrenia and Affective Disorders

Total 107 results

VA Greater Los Angeles Healthcare System
National Alliance for Research in Schizophrenia and Affective Disorders

Completed

Pharmacological Approach to Improve the Outcome of Social Cognition Training

Schizophrenia

United States
Mclean Hospital
National Association for Research on Schizophrenia and Affective Disorders.

Completed

The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression

Depression | Major Depressive Disorder | Unipolar Depression

United States
National Alliance for Research on Schizophrenia...

Completed

Cognitive Remediation and Functional Skills Training in Schizophrenia

Schizophrenia | Schizoaffective Disorder

Canada
Cambridge Health Alliance
National Alliance for Research on Schizophrenia and Depression

Completed

Natural Supplements for Unipolar Depression

Unipolar Depression

United States
Northwell Health
National Alliance for Research on Schizophrenia and Depression

Completed

Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression

Bipolar Depression | Unipolar Depression

United States
Stanford University
National Alliance for Research on Schizophrenia and Depression

Terminated

Imaging the Nucleus Accumbens in Major Depressed Patients 'Treated With Pramipexole

Depression

United States
Vanderbilt University
National Alliance for Research on Schizophrenia and Depression

Completed

Quantifying Abnormalities in Cortical Activation Associated With Auditory Hallucinations Using Functional Magnetic Resonance Imaging

Schizophrenia | Schizoaffective Disorder | Hallucinations

United States
Yale University
National Alliance for Research on Schizophrenia and Depression

Completed

A Pilot Trial of Acute N-Acetylcysteine Effects on Working Memory and Other Cognitive Functions in Schizophrenia (NAC)

Schizophrenia

United States
Yale University
National Alliance for Research on Schizophrenia and Depression

Completed

Ketamine Infusion for Obsessive-Compulsive Disorder

Obsessive-compulsive Disorder

United States
Yale University
National Alliance for Research on Schizophrenia and Depression

Completed

Effects of Atomoxetine on Cognitive Function in Schizophrenia

Smoking | Schizophrenia | Cognition

United States
Northwestern University
National Alliance for Research on Schizophrenia and Depression

Completed

Serotonin 1A Agonists and Cognition in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Northwestern University
National Alliance for Research on Schizophrenia and Depression

Terminated

Estimating and Reducing the Cardiovascular Risk of Patients With Schizophrenia Drugs From Lipid Measures and Ischemic Electrocardiographic Changes

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

United States
Northwell Health
National Alliance for Research on Schizophrenia and Depression

Completed

Liothyronine (T3) for Bipolar Depression (T3)

Depression | Bipolar Disorder

United States
Yale University
National Alliance for Research on Schizophrenia and Depression

Completed

Galantamine for Cognitive Deficits in Schizophrenia

Schizophrenia

United States
Yale University
National Alliance for Research on Schizophrenia and Depression

Completed

GABA-glutamate Interactions and Psychosis

Cognitive Dysfunction

United States
Yale University
National Alliance for Research on Schizophrenia and Depression

Completed

Effects of Salvinorin A in Healthy Controls

Healthy

United States
Yale University
National Alliance for Research on Schizophrenia and Depression

Completed

Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence

Depression | Alcohol Dependence

United States
Mclean Hospital
National Alliance for Research on Schizophrenia and Depression

Unknown

Functional Brain Imaging Study of Response to Repetitive TMS (rTMS) Treatment of Major Depression

Major Depression

United States
Mclean Hospital
National Alliance for Research on Schizophrenia and Depression

Completed

CoQ10 in Geriatric Bipolar Depression (CoQ10)

Bipolar Depression

United States
Herzog Hospital
National Alliance for Research on Schizophrenia and Depression

Completed

D-cycloserine for Major Depressive Disorder

Major Depressive Disorder

Israel
Mclean Hospital
National Alliance for Research on Schizophrenia and Depression; Pfizer

Completed

Magnetic Resonance Imaging Study of Geriatric Depression

Major Depressive Disorder

United States
University of Cincinnati
National Alliance for Research on Schizophrenia and Depression

Completed

Peroxisomal Defects and Familial Risk for Bipolar Disorder

Bipolar Disorder | Mania

United States
Vanderbilt University
National Alliance for Research on Schizophrenia and Depression; Abbott

Completed

Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?

Schizophrenia | Schizoaffective Disorder

United States
Massachusetts General Hospital
National Alliance for Research on Schizophrenia and Depression

Terminated

Study of Maca Root to Treat Sexual Dysfunction Associated With the Treatment Regimen for Bipolar Disorder in Females

Sexual Dysfunction | Bipolar Disorder

United States
Montefiore Medical Center
National Alliance for Research on Schizophrenia and Depression

Completed

Intranasal Oxytocin for the Treatment of Autism Spectrum Disorders (INOT)

Autism Spectrum Disorders

United States
Northwestern University
National Alliance for Research on Schizophrenia and Depression; Pfizer

Completed

Anticonvulsant Mood Stabilizers, Antipsychotic Drugs and the Insulin Resistance Syndrome

Schizophrenia | Schizoaffective Disorder | Bipolar Disorder

United States
University of Pittsburgh
National Alliance for Research on Schizophrenia and Depression

Completed

Buprenorphine for Treatment Resistant Depression (BUP-TRD)

Depressive Disorder | Depression | Depressive Disorder, Major

United States
University of Pittsburgh
National Alliance for Research on Schizophrenia and Depression

Completed

Psychotherapy for Bipolar II Depression, Pilot Study, Phase II

Bipolar II Disorder

United States
Thomas Jefferson University
National Alliance for Research on Schizophrenia and Depression

Completed

Excessive Sweating Caused by Antidepressants: Measurement and Treatment With Terazosin (ADIES)

Hyperhidrosis

United States
University of Pittsburgh
National Alliance for Research on Schizophrenia and Depression

Completed

Sensoril(Ashwaganhda)for Bipolar Disorder

Bipolar I Disorder | Bipolar II Disorder | Bipolar Disorder NOS

United States
University of Calgary
National Alliance for Research on Schizophrenia and Depression

Completed

Effects of Cognitive Remediation on Cognition in Young People at Clinical High Risk of Psychosis

Prodromal Schizophrenia
Massachusetts General Hospital
National Alliance for Research on Schizophrenia and Depression

Completed

Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism

Alcohol Dependence | Major Depressive Disorder | Alcohol Abuse

United States
Sheba Medical Center
National Alliance for Research on Schizophrenia and Depression

Unknown

Testosterone Replacement in Middle-Aged Hypogonadal Men With Dysthymia: Parallel Group, Double Blind Randomized Trial

Dysthymic Disorder

Israel
Centre for Addiction and Mental Health
National Alliance for Research on Schizophrenia and Depression

Completed

Antipsychotic Medication Extended Dosing Study

Schizophrenia

Canada
Massachusetts General Hospital
National Alliance for Research on Schizophrenia and Depression

Completed

Folate Supplementation in Schizophrenia

Schizophrenia

United States
Massachusetts General Hospital
National Alliance for Research on Schizophrenia and Depression

Completed

Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in Depression

Major Depressive Disorder

United States
Stanford University
National Alliance for Research on Schizophrenia and Depression; Abbott

Completed

Depakote ER in Bipolar Depression

Depression, Bipolar

United States
Massachusetts General Hospital
National Alliance for Research on Schizophrenia and Depression

Terminated

Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features

Metabolic Syndrome | Major Depressive Disorder | Major Depressive Disorder w/ Psychotic Features

United States
University of Pittsburgh
National Alliance for Research on Schizophrenia and Depression

Completed

L-Carnosine for Bipolar I Disorder

Bipolar I Disorder

United States
University of Chicago
National Alliance for Research on Schizophrenia and Depression

Completed

Primary Care Based Depression Prevention for Adolescents/Young Adults/Young Adults and Young Adults (CATCH-IT)

Depression

United States
University of Pennsylvania
National Alliance for Research on Schizophrenia and Depression

Completed

Cognitive Therapy for Negative Symptoms and Functioning

Schizophrenia | Schizoaffective Disorder

United States
Vanderbilt University
National Alliance for Research on Schizophrenia and Depression; Cephalon

Completed

Effects of Armodafinil on Cognition for Patients With Schizophrenia or Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
Université de Montréal
National Alliance for Research on Schizophrenia and Depression

Unknown

Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia

Tardive Dyskinesia

Canada
Massachusetts General Hospital
National Alliance for Research on Schizophrenia and Depression

Completed

Biochemical Brain Changes Correlated With The Antidepressant Effect Of Thyroid Hormones

Major Depressive Disorder

United States
Seattle Institute for Biomedical and Clinical Research
National Alliance for Research on Schizophrenia and Depression

Completed

Effect of Estrogen & Stress for Postmenopausal Women

Aging
Cedars-Sinai Medical Center
National Alliance for Research on Schizophrenia and Depression

Completed

Allopurinol Add-on Treatment for Refractory Mania

Bipolar Disorder | Mixed Mania | Treatment-Resistant Mania

United States
University of California, Davis
National Alliance for Research on Schizophrenia and Depression

Completed

A Pilot Study on Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Bipolar Depression (TMS-BD)

Depression | Bipolar Disorder | Major Depression | Mood Disorder

United States
University of Colorado, Denver
National Alliance for Research on Schizophrenia and Depression

Terminated

The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes

Schizophrenia

United States
Beersheva Mental Health Center
National Alliance for Research on Schizophrenia and Depression

Completed

Creatine Treatment in Psychiatric Disorders

Schizophrenia

Israel
University Health Network, Toronto
National Alliance for Research on Schizophrenia and Depression

Completed

Deep Brain Stimulation for Refractory Major Depression

Major Depressive Disorder

Canada

Clinical Trials Sponsored by National Alliance for Research in Schizophrenia and Affective Disorders

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Senegal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations